Literature DB >> 8712132

Prognostic value of predischarge exercise testing, ejection fraction, and ventricular ectopic activity in acute myocardial infarction treated with streptokinase.

R S Khattar1, S K Basu, U Raval, R Senior, A Lahiri.   

Abstract

The relative importance of prognostic parameters that delineate left ventricular function, myocardial ischemia, and arrhythmogenic potential after thrombolytic therapy is not clear. This study investigated 112 patients with acute myocardial infarction who were treated with thrombolysis to determine the relative prognostic value of predischarge treadmill exercise testing, radionuclide ventriculography, and ambulatory electrocardiographic monitoring for ventricular ectopic activity. During a mean follow-up period of 18 months (range 6 to 30), 42 first cardiac events were recorded, consisting of 3 deaths, 6 reinfarctions, 16 bouts of unstable angina, 16 episodes of heart failure, and 1 arrhythmic event. Univariate analysis revealed ejection fraction, exercise time, and ventricular ectopic count of > or = 10/hour to be predictive of future cardiac events. Subsequent multivariate analysis showed ejection fraction (p <0.001) and exercise time (p=0.002 to have independent prognostic value, but ventricular ectopic activity did not provide additional information. Ventricular ectopic count > or = 10/hour was additionally predictive only when combined with either ejection fraction (R2=5.4%) or exercise time (R2=2.9%). Event-free survival analysis revealed hazard ratios for ejection fraction <40% and exercise time <7 minutes of 3.63 (p=0.001) and 2.16 (p=0.01), respectively. Although ejection fraction and exercise time were able to predict future episodes of heart failure, neither could adequately identify patients at risk of recurrent ischemic events.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712132     DOI: 10.1016/s0002-9149(96)90385-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Risk stratifying patients who survive an acute myocardial infarction.

Authors:  M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

2.  Prognostic assessment of uncomplicated first myocardial infarction by exercise echocardiography and Tc-99m tetrofosmin gated SPECT.

Authors:  J Candell-Riera; J Llevadot; C Santana; J Castell; S Aguadé; L Armadans; B Bermejo; G Oller; H García-del-Castillo; M Soler-Peter; J Soler-Soler
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

3.  Long-term clinical outcome of ST-segment elevation myocardial infarction patients with and without diabetes mellitus in the Zwolle trial.

Authors:  J R Timmer; I C C van der Horst; J P S Henriques; K Thomas; H J G Bilo; J C A Hoorntje; M J de Boer; H Suryapranata; F Zijlstra
Journal:  Neth Heart J       Date:  2003-10       Impact factor: 2.380

4.  Survival of patients receiving fibrinolytic therapy for acute ST-segment elevation myocardial infarction in a developing country - patient characteristics and predictors of mortality.

Authors:  Fahim H Jafary; Ahmad Zafir Arham; Fahad Waqar; Ali Raza; Hafeez Ahmed
Journal:  J Thromb Thrombolysis       Date:  2007-10-30       Impact factor: 2.300

5.  Multicenter trial on prognostic value of inducible ischemia, assessed by dobutamine stress echocardiography and exercise electrocardiography test, in patients with uncomplicated myocardial infarction, treated with thrombolytic therapy.

Authors:  A Galati; R Bigi; C Coletta; C Fiorentini; R Ricci; G Occhi; A Sestili; F Rulli; N Aspromonte; M S Fera; G Greco; G Guagnozzi; V Ceci
Journal:  Int J Card Imaging       Date:  1998-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.